Q3 2017 SALES OF €88.3 MILLION, UP 5.2% AT CONSTANT EXCHANGE RATES
For the third quarter of 2017, the Vetoquinol Group posted sales of €88.3 million, up 5.2% from Q3 2016 at constant exchange rates. Sales of Essential products, driver of the Group’s strategy, came to €41.9 million, up 16.7% like-for-like. All three territories posted strong growth at constant exchange rates, particularly Asia Pacific (10.5%), while Europe and the Americas both recorded 4.1% growth.
- Public releases
Vetoquinol has been listed on the Euronext Paris stock market since November 16th.
Composition of the bodies of Corporate Management and Governance
Financial information and key figures: annual, half-year and by sector key figures